SLC24A3-AS1

Across TCGA pan-cancer cohorts, SLC24A3-AS1 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of SLC24A3-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where SLC24A3-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types SLC24A3-AS1 is over-expressed in tumor, although a few such as THCA and UCEC show the opposite, repressed pattern.

THCA, UCEC, and BLCA are the cancer types where SLC24A3-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC24A3-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.050	<.001	8	view →
UCEC	All	II,III,IV	−0.161	.001	6	view →
BLCA	All	All	−0.109	.010	6	view →
LUAD	All	III,IV	−0.090	.010	3	view →
COAD	All	IV	−0.045	.005	2	view →
CHOL	All	All	+0.073	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

SLC24A3-AS1–THCA

Open the THCA breakdown →